Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marloes E. van Muijen"'
Autor:
Marloes E. van Muijen, Sarah E. Thomas, Douwe Vellinga, Silke Bouwman, Martijn B.A. van Doorn, Klaziena Politiek, Marisol E. Otero, Juul M.P.A. van den Reek, Elke M.G.J. de Jong
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/f56aae0ea10b4cf7b759c218087ff36e
Autor:
Marloes E. van Muijen, Sarah E. Thomas, Hans M.M. Groenewoud, Marisol E. Otero, Paul M. Ossenkoppele, Marcellus D. Njoo, Sharon R.P. Dodemont, Else N. Kop, Maartje A.M. Berends, Marjolein I.A. Koetsier, Johannes M. Mommers, John E.M. Körver, Ron A. Tupker, Marjolein S. de Bruin-Weller, Lizelotte J.M.T. Weppner-Parren, Bas Peters, Marloes M. Kleinpenning, Astrid L.A. Kuijpers, W. Peter Arnold, Paula P.M. van Lümig, Juul M.P.A. van den Reek, Elke M.G.J. de Jong
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Real-world evidence, directly comparing the effectiveness of interleukin (IL)17-inhibitors, IL23-inhibitors, tumour necrosis factor alpha (TNF-α)-inhibitors and an IL12/23-inhibitor in psoriasis, is scarce. The aim of this study was to directly comp
Externí odkaz:
https://doaj.org/article/e146b3b81ecf4e69ba49684069d330cc
Autor:
Elke M G J de Jong, Hans Groenewoud, Tamara W van Hal, Juul M. P. A. van den Reek, Marloes E van Muijen
Publikováno v:
Psoriasis: Targets and Therapy
Psoriasis. Targets and Therapy, 10, 29-37
Psoriasis. Targets and Therapy, 10, pp. 29-37
Psoriasis. Targets and Therapy, 10, 29-37
Psoriasis. Targets and Therapy, 10, pp. 29-37
Background Previously identified risk factors for psoriatic arthritis (PsA); nail dystrophy and scalp lesions are highly prevalent in patients with moderate-to-severe psoriasis. Therefore, these variables may not be useful as predictors for PsA in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1fe0353985959557e38b78d6bf6fd37
https://doi.org/10.2147/ptt.s270619
https://doi.org/10.2147/ptt.s270619
Autor:
J.M.P.A. van den Reek, E.M.G.J. de Jong, L.J. van Vugt, L M D Vandermaesen, Marloes E van Muijen, Selma Atalay
Publikováno v:
Drugs-Real World Outcomes, 8, 163-172
Drugs-Real World Outcomes
Drugs-Real World Outcomes, 8, 2, pp. 163-172
Drugs-Real World Outcomes
Drugs-Real World Outcomes, 8, 2, pp. 163-172
Background Personal treatment goals have been systematically investigated in psoriasis patients with active but not in controlled disease. Objectives To explore patient needs in psoriasis patients with controlled disease due to biologic therapy with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::961464d5ca122d8b73234b7e3161627a
http://hdl.handle.net/2066/235078
http://hdl.handle.net/2066/235078
